Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium

Published:2021-12-27 Issue: Volume: Page:1-10
ISSN:1784-3286
Container-title:Acta Clinica Belgica
language:en
Short-container-title:Acta Clinica Belgica

Author:

Jorissen Winde¹^ORCID,Annemans Lieven²^ORCID,Louis Nicolas³^ORCID,Nilsson Andreas⁴^ORCID,Willis Michael⁴^ORCID

Affiliation:

1. Mundipharma B.V., Mechelen, Belgium

2. Faculty of Medicine and Health Science, Department of Public Health, Ghent University, Gent, Belgium

3. Mundipharma Medical Company, Basel, Switzerland

4. The Swedish Institute for Health Economics, Lund, Sweden

Funder

Mundipharma B.V. Belgium

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17843286.2021.2015554

Reference39 articles.

1. Intermutualistic Agency Atlas. [cited Sept 2021]. Available from: http://atlas.aim-ima.be/base-de-donnees;

2. Diabetic Kidney Disease

3. Kidney Disease and Increased Mortality Risk in Type 2 Diabetes

4. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective;Diabetes, Obesity and Metabolism;2024-06-10

3. Applications of SGLT2 inhibitors beyond glycaemic control;Nature Reviews Nephrology;2024-04-26

4. Focus on cardiometabolic risk factors;Acta Cardiologica;2023-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3